These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


129 related items for PubMed ID: 3686446

  • 1. [Several homeostatic renal functions in hypertensive and nephrotic syndromes of chronic functionally compensated glomerulonephritis].
    Brodskiĭ MA, Ratner MIa.
    Ter Arkh; 1987; 59(8):51-5. PubMed ID: 3686446
    [Abstract] [Full Text] [Related]

  • 2. [The tubulointerstitial component of chronic glomerulonephritis: its clinico-functional diagnosis].
    Ratner MIa, Brodskiĭ MA, Zubkin ML, Stenina II, Slutskin IM.
    Ter Arkh; 1991; 63(6):12-5. PubMed ID: 1948727
    [Abstract] [Full Text] [Related]

  • 3. [The clinical significance of renal functional reserve].
    Zverev KV, Kutyrina IM, Gersimenko OI.
    Klin Med (Mosk); 1995; 73(3):99-102. PubMed ID: 8577129
    [Abstract] [Full Text] [Related]

  • 4. [The role of tubular interstitial changes in the genesis of the rapid progression of chronic glomerulonephritis].
    Ratner MIa, Serov VV, Shumakov VI.
    Urol Nefrol (Mosk); 1995; (3):7-9. PubMed ID: 7618227
    [Abstract] [Full Text] [Related]

  • 5. Participation of renal prostaglandins in the nephrotic syndrome.
    Ruilope L, Millet VG, Alcazar JM, Prieto C, Tresguerres JA, Garcia-Robles R, Sancho J, Rodicio JL.
    Proc Eur Dial Transplant Assoc; 1983; 19():738-43. PubMed ID: 6576332
    [Abstract] [Full Text] [Related]

  • 6. [Clinico-morphological comparisons in patients with chronic glomerulonephritis and elevated arterial pressure].
    Gadaev AG, Akimova SL.
    Urol Nefrol (Mosk); 1993; (5):33-6. PubMed ID: 8310582
    [Abstract] [Full Text] [Related]

  • 7. [Clinical implication of urine test for markers of endothelial dysfunction and angiogenesis factors in assessment of tubulointerstitial fibrosis in chronic glomerulonephritis].
    Bobkova IN, Kozlovskaia LV, Rameeva AS, Varshavskiĭ VA, Golitsyna EP.
    Ter Arkh; 2007; 79(6):10-5. PubMed ID: 17684960
    [Abstract] [Full Text] [Related]

  • 8. [Features of a cytokine profile in patients with chronic glomerulonephritis with progressive chronic renal failure].
    Koriakova NN, Rozhdestvenskaia ED, Kazantseva SV, Bushueva TV, Valamina IE.
    Ter Arkh; 2006; 78(5):14-7. PubMed ID: 16889043
    [Abstract] [Full Text] [Related]

  • 9. [The dependence of the progression of chronic glomerulonephritis on the clinical and morphological types of glomerulonephritis and on the tubulointerstitial changes].
    Ratner MIa, Fedorova ND.
    Urol Nefrol (Mosk); 1998; (2):22-4. PubMed ID: 9577698
    [Abstract] [Full Text] [Related]

  • 10. [Lipiduria in the nephrotic syndrome].
    Neverov NI, Nikitina EA.
    Ter Arkh; 1992; 64(6):16-8. PubMed ID: 1440328
    [Abstract] [Full Text] [Related]

  • 11. [The catamnestic assessment of the efficacy of combined pathogenetic therapy in patients with different clinico-morphological variants of chronic glomerulonephritis].
    Ratner MIa, Serov VV, Varshavskiĭ VA, Biriukova LS, Stenina II.
    Ter Arkh; 1990; 62(6):42-6. PubMed ID: 2218925
    [Abstract] [Full Text] [Related]

  • 12. [Lipid peroxidation and the system of antioxidant protection in patients with chronic glomerulonephritis and normal kidney azoturic function].
    Riabov SI, Kulikova AI, Tugusheva FA, Zubina IM, Kozlov VV.
    Ter Arkh; 1995; 67(12):33-7. PubMed ID: 8820054
    [Abstract] [Full Text] [Related]

  • 13. [Comparison of biopsy an partial kidney function data in chronic glomerulonephritis].
    Ratner NA, Vikhert AM, Kramer AA, aĭkova DA, Kul'dova SKh.
    Klin Med (Mosk); 1970 Jul; 48(7):25-33. PubMed ID: 5494090
    [No Abstract] [Full Text] [Related]

  • 14. [Histomorphological tubulointerstitial changes in progression of chronic glomerulonephritis].
    Ratner MIa, Fedorova ND.
    Urologiia; 2000 Jul; (1):28-30. PubMed ID: 16856458
    [Abstract] [Full Text] [Related]

  • 15. [Variants in the transient deterioration of kidney function in chronic glomerulonephritis].
    Riabov SI, Stavskaia VV.
    Ter Arkh; 1996 Jul; 68(11):62-7. PubMed ID: 9045385
    [Abstract] [Full Text] [Related]

  • 16. [Urine excretion of a monocytic chemotaxic protein-1 and a transforming growth factor beta1 as an indicator of chronic glomerulonephritis progression].
    Bobkova IN, Chebotareva NV, Kozlovskaia LV, Varshavskiĭ VA, Golitsyna EP.
    Ter Arkh; 2006 Jul; 78(5):9-14. PubMed ID: 16889042
    [Abstract] [Full Text] [Related]

  • 17. Clinical features of benign hypertensive nephrosclerosis at time of renal biopsy.
    Innes A, Johnston PA, Morgan AG, Davison AM, Burden RP.
    Q J Med; 1993 Apr; 86(4):271-5. PubMed ID: 8327642
    [Abstract] [Full Text] [Related]

  • 18. [Prognostic factors of chronic glomerulonephritis and chronic non-inflammatory glomerulopathies rapid progression].
    Ratner MIa, Serov VV, Varshavskiĭ VA, Fedorova ND.
    Ter Arkh; 1998 Apr; 70(6):7-11. PubMed ID: 9695214
    [Abstract] [Full Text] [Related]

  • 19. Changes in renal haemodynamics in the nephrotic syndrome.
    Zabka J, Stríbrná J, Janata V, Matousovic K.
    Physiol Bohemoslov; 1989 Apr; 38(1):51-4. PubMed ID: 2524077
    [Abstract] [Full Text] [Related]

  • 20. [Experience in the use of valsartan with the aim to inhibit progression of kidney failure in patients with chronic glomerulonephritis].
    Shvetsov MIu, Medvedeva TIu, Kozlovskaia NL, Miroshnichenko NG, Okonova EB, Shonichev DG, Rudenko TE, Stavrovskaia EV, Plieva OK.
    Ter Arkh; 2001 Apr; 73(6):55-61. PubMed ID: 11521525
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.